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Introduction

Alpha 1 antitrypsin (a1 Al) deficiency and its
association with the pathogenesis of liver disease continues to be controversial. Recent biochemical characterization also indicates that its involvement in liver
disease is obscurer . The deficiency itself may not be a
cause of liver disease as it occurs with almost the same
frequency in patients with and without liver disease2'3.
The present study was conducted to determine the
association of serum alpha 1 antitrypsin with various
types of acute and chronic liver diseases.

Mean serum alpha 1 antitrypsin concentration by
RID in healthy controls was 2.47-1.-0.08 g/1 (range
0.52-5.0 g/1). Any value less than 2.0 g/1 was considered
lower than normal. In patients with AVH the concentration varied from 0.52-4.7 g/I (mean 3.2 ± 0.11 g/1). With
the exception of one patient, all others had values within
the normal expected range, while 12% cirrhotics had low
concentrations, mean being 2.71 ±0.11 g/l. IEF profile in
controls showed that phenotype MM predominates
(70%) followed by M1 M2 (28%) and FM3 (2%). MM is
also the most common phenotype in patients with AVH
(72%) and cirrhosis (52%) while M1 M2 was found in 28%
and 48% of the patients respectively.

Patients, Methods and Results
Comments

Fifty patients suffering from acute viral hepatitis
(AVH), 50 biopsy proven cirrhotics and 100 healthy
adults were selected. Controls were included on the
basis of normal liver function tests whereas liver diseases
were classified on clinical examination, biochemical
investigations, i.e., liver function tests and liver biopsy.
Raised aspartate and alanine transaminase (three times
the normal) was the criteria for selecting patients with
AVH while all cirrhotics were biopsy proven. Age and sex
distribution in controls and patients with liver disease is
Table. Age and sex distribution in controls and patients with AYH
and cirrhosis.
Groups

Sex
M

Controls
(100)
Acute viral
hepatitis
(50)
Cirrhosis
(50)

F

52

48

37

13

26

24

Age (years)
Mean (range)

References

33
(18-82)
32
(18-60)
42
(18-75)

presented in the accompanying table.
Quantitative measurement of serum alpha 1 antitrypsin was carried out by single radial immunodiffusion (RID) technique using M. Partigen immunodiffusion plates4 (Behring Diagnostic) while phenotyping
was done by ultra thin layer polyacrylamide gel
isoelectric focussing (IEF) and for further confirmation
of alpha 1 antitrypsin bands we used immunofixation
techniques.

72

The present findings indicate that almost 98% of the
patients with acute viral hepatitis had values within the
normal expected range while 12% cirrhotics manifested
low levels. These low levels, however, appear to be of no
diagnostic significance as not a single sera exhibited total
or intermediate deficiency phenotype when subjected to
isoelectric focussing. The study therefore supports the
notion that phenotypes associated with both total or
intermediate deficiencies are less in our local population
than in Europeans6'7 and American caucasians8.
Phenotype MM overwhelmingly dominates all
other types and thus can be regarded as the normal type
for our population.
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